BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 10565811)

  • 21. Serotonin mechanisms in chemotherapy-induced emesis in cancer patients.
    Cubeddu LX
    Oncology; 1996 Jun; 53 Suppl 1():18-25. PubMed ID: 8692546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleus accumbens serotonin1A receptors control cocaine-induced hyperactivity but not local serotonin increase: an in vivo microdialysis study.
    Müller CP; Thönnessen H; De Souza Silva MA; Fink H; Bert B; Carey RJ; Huston JP
    Neuropharmacology; 2004 Aug; 47(2):205-15. PubMed ID: 15223299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of peptide YY correlate with cisplatin-induced emesis in dogs.
    Perry MR; Rhee J; Smith WL
    J Pharm Pharmacol; 1994 Jul; 46(7):553-7. PubMed ID: 7996381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children.
    Matera MG; Di Tullio M; Lucarelli C; Casale F; Calabria C; Lampa E; Indolfi P; Rossi F
    J Med; 1993; 24(2-3):161-70. PubMed ID: 7691978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of granisetron, a selective 5-HT3 receptor antagonist, on ouabain-induced emesis in ferrets.
    Endo T; Sugawara J; Nemoto M; Minami M; Blower PR
    Res Commun Mol Pathol Pharmacol; 1998 Dec; 102(3):227-39. PubMed ID: 10342910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
    Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
    J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Comparison of Oral Ondansetron and Intravenous Granisetron for the Prevention of Nausea and Emesis Associated with Cisplatin-Based Chemotherapy.
    Spector JI; Lester EP; Chevlen EM; Sciortino D; Harvey JH; Whaley W; Madajewicz S; Isaacs R; Homesley HD; Yee S; Beck TM; Tchekmedyian NS; Crawford KH; Ames M; Creed MR
    Oncologist; 1998; 3(6):432-438. PubMed ID: 10388135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
    Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release and metabolism of 5-hydroxytryptamine in the cat spinal cord examined with microdialysis.
    Sorkin LS; Hughes MG; Liu D; Willis WD; McAdoo DJ
    J Pharmacol Exp Ther; 1991 Apr; 257(1):192-9. PubMed ID: 1708424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
    Atkinson W; Lockhart S; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2006 Jan; 130(1):34-43. PubMed ID: 16401466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An outline of 5-HT3 receptor antagonists (1)--In pharmacological actions].
    Tsukagoshi S; Ohta J; Taguchi T
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2108-14. PubMed ID: 8239673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that the branched-chain amino acid L-valine prevents exercise-induced release of 5-HT in rat hippocampus.
    Gomez-Merino D; Béquet F; Berthelot M; Riverain S; Chennaoui M; Guezennec CY
    Int J Sports Med; 2001 Jul; 22(5):317-22. PubMed ID: 11510866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
    Spitzer TR; Friedman CJ; Bushnell W; Frankel SR; Raschko J
    Bone Marrow Transplant; 2000 Jul; 26(2):203-10. PubMed ID: 10918432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vivo microdialysis measurement of 5-hydroxytryptamine and its metabolites, 5-hydroxyindoleacetic acid and N-acetyl 5-hydroxytryptamine, in rat blood: effects of histamine-receptor antagonists.
    Sakurai E; Monura A; Yamakami J; Hikichi N
    J Pharm Pharmacol; 1996 Sep; 48(9):911-3. PubMed ID: 8910852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
    Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous ondansetron plus intravenous dexamethasone with different ondansetron dosing schedules during multiple cycles of cisplatin-based chemotherapy.
    Chen PT; Liaw CC
    Chang Gung Med J; 2008; 31(2):167-74. PubMed ID: 18567417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of intraplatelet and urinary 5-hydroxytryptamine (5-HT), and urinary 5-hydroxyindoleacetic acid (5-HIAA) levels in patients with toxemia of pregnancy.
    Ishii Y; Kanai H; Maezawa A; Tsuchida A; Yano S; Naruse T
    Res Commun Chem Pathol Pharmacol; 1993 Apr; 80(1):21-40. PubMed ID: 7683821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial.
    Cheirsilpa A; Sinthusake T; Songsakkaesorn A; Visawaprasit S; Chulaka K; Changkuingdee N
    Jpn J Clin Oncol; 2005 Dec; 35(12):695-9. PubMed ID: 16319109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between cancer chemotherapeutic drug-induced delayed emesis and plasma levels of substance P in two patients with small cell lung cancer].
    Matsumoto S; Kawasaki Y; Mikami M; Nakamoto M; Tokuyasu H; Kometani Y; Chikumi H; Hitsuda Y; Matsumoto Y; Sasaki T
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):535-8. PubMed ID: 10097753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of granisetron and its combination with dexamethasone on cisplatin-induced delayed emesis in the ferret.
    Fukunaka N; Sagae S; Kudo R; Endo T; Hirafuji M; Minami M
    Gen Pharmacol; 1998 Nov; 31(5):775-81. PubMed ID: 9809477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.